[go: up one dir, main page]

FR2810547B1 - Utilisation d'acides en c2-c10 pour la prevention des infections a bacteries a gram negatif - Google Patents

Utilisation d'acides en c2-c10 pour la prevention des infections a bacteries a gram negatif

Info

Publication number
FR2810547B1
FR2810547B1 FR0008383A FR0008383A FR2810547B1 FR 2810547 B1 FR2810547 B1 FR 2810547B1 FR 0008383 A FR0008383 A FR 0008383A FR 0008383 A FR0008383 A FR 0008383A FR 2810547 B1 FR2810547 B1 FR 2810547B1
Authority
FR
France
Prior art keywords
prevention
acids
bacteria infections
gram bacteria
negative gram
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0008383A
Other languages
English (en)
Other versions
FR2810547A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0007992A external-priority patent/FR2810546A1/fr
Application filed by Institut Pasteur filed Critical Institut Pasteur
Priority to FR0008383A priority Critical patent/FR2810547B1/fr
Priority to EP01947582A priority patent/EP1292291A2/fr
Priority to AU2001269239A priority patent/AU2001269239A1/en
Priority to US10/312,047 priority patent/US20040116523A1/en
Priority to PCT/FR2001/001971 priority patent/WO2001097791A2/fr
Priority to CA002413284A priority patent/CA2413284A1/fr
Publication of FR2810547A1 publication Critical patent/FR2810547A1/fr
Publication of FR2810547B1 publication Critical patent/FR2810547B1/fr
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR0008383A 2000-06-22 2000-06-29 Utilisation d'acides en c2-c10 pour la prevention des infections a bacteries a gram negatif Expired - Fee Related FR2810547B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0008383A FR2810547B1 (fr) 2000-06-22 2000-06-29 Utilisation d'acides en c2-c10 pour la prevention des infections a bacteries a gram negatif
PCT/FR2001/001971 WO2001097791A2 (fr) 2000-06-22 2001-06-22 Utilisation d'acides en c4-c10 pour la prévention des infections a bactéries a gram négatif
AU2001269239A AU2001269239A1 (en) 2000-06-22 2001-06-22 Use of c4-c10 acids for preventing gram-negative bacterial infections
US10/312,047 US20040116523A1 (en) 2000-06-22 2001-06-22 Use of c4-c10 acids for preventing gram-negative bacterial infections
EP01947582A EP1292291A2 (fr) 2000-06-22 2001-06-22 Utilisation d'acides en c 4-c10 pour la prevention des infections a bacteries a gram-negatif
CA002413284A CA2413284A1 (fr) 2000-06-22 2001-06-22 Utilisation d'acides en c4-c10 pour la prevention des infections a bacteries a gram negatif

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0007992A FR2810546A1 (fr) 2000-06-22 2000-06-22 Utilisation d'acides en c2-c10 pour la prevention des infections a bacteries a gram negatif
FR0008383A FR2810547B1 (fr) 2000-06-22 2000-06-29 Utilisation d'acides en c2-c10 pour la prevention des infections a bacteries a gram negatif

Publications (2)

Publication Number Publication Date
FR2810547A1 FR2810547A1 (fr) 2001-12-28
FR2810547B1 true FR2810547B1 (fr) 2004-01-30

Family

ID=26212484

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0008383A Expired - Fee Related FR2810547B1 (fr) 2000-06-22 2000-06-29 Utilisation d'acides en c2-c10 pour la prevention des infections a bacteries a gram negatif

Country Status (6)

Country Link
US (1) US20040116523A1 (fr)
EP (1) EP1292291A2 (fr)
AU (1) AU2001269239A1 (fr)
CA (1) CA2413284A1 (fr)
FR (1) FR2810547B1 (fr)
WO (1) WO2001097791A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1291015A1 (fr) 2001-09-10 2003-03-12 Lunamed AG Compositions à libération prolongée d'un agent actif
US8399515B2 (en) * 2003-05-20 2013-03-19 Baylor Research Institute Five and fifteen carbon fatty acids for treating metabolic disorders and as nutritional supplements
WO2009087474A2 (fr) * 2008-01-08 2009-07-16 Akthelia Pharmaceuticals Agonistes pour des systèmes peptidiques antimicrobiens
EP2215913A1 (fr) † 2009-01-23 2010-08-11 Nutreco Nederland B.V. Additif d'aliment de bétail et aliment de bétail comprenant des esters alcoyls d'acides gras de longueur de chaîne intermédiaire, et leur utilisation dans les aliments de bétail
US9427498B2 (en) 2009-03-26 2016-08-30 Organic Medical Ventures, L.L.C. Syringe treated with transdermal venous access locking solutions and method of treating the syringe
US9433209B2 (en) 2009-03-26 2016-09-06 Organic Medical Ventures, L.L.C. Transdermal venous access locking solutions
US9072296B2 (en) 2009-03-26 2015-07-07 Organic Medical Ventures, L.L.C. Transdermal venous access locking solutions
US20100249747A1 (en) * 2009-03-26 2010-09-30 Organic Medical Ventures, L.L.C. Transdermal venous access locking solution
EP3220744A4 (fr) 2014-11-19 2018-08-01 Kansas State University Research Foundation Composés d'atténuation chimique dans l'alimentation animale et ingrédients pour l'alimentation animale
SE538436C2 (en) * 2014-12-09 2016-06-28 Perstorp Ab Composition inhibiting gram-negative pathogens in galloanserans

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2466663A (en) * 1944-10-20 1949-04-05 Ward Baking Co Fungicide containing caprylic acid and its salt
US4489097A (en) * 1976-07-28 1984-12-18 The Procter & Gamble Company Intravenous solutions with antimicrobial agent
EP0021504B1 (fr) * 1979-06-25 1984-10-03 THE PROCTER & GAMBLE COMPANY Article utilisable comme cathéter ou analogue
US4406884A (en) * 1981-06-23 1983-09-27 The Procter & Gamble Company Topical antimicrobial composition
GB8525061D0 (en) * 1985-10-10 1985-11-13 Bp Chem Int Ltd Antimicrobial additives
JPS6453627A (en) * 1987-05-29 1989-03-01 Ricoh Kk Level shifter circuit device
JP2581716B2 (ja) * 1987-12-10 1997-02-12 日宝化学株式会社 毒素原性大腸菌症予防治療剤
US5434182A (en) * 1987-12-31 1995-07-18 Isaacs; Charles E. Antibacterial fatty acid compositions
US5234719A (en) * 1991-06-04 1993-08-10 Ecolab Inc. Food additive sanitizing compositions
FI100376B (fi) * 1995-02-06 1997-11-28 Kemira Oyj Uusi säilöntäainekoostumus
DE19505518A1 (de) * 1995-02-10 1996-08-14 Ina Dr Levi Mittel zur Behandlung von Malaria, Hepatitis-B-Infektionen, Krebserkrankungen und systemischen opportunistischen Infektionen
JPH08325107A (ja) * 1995-06-01 1996-12-10 Takasago Internatl Corp 抗菌剤
DE69637449T2 (de) * 1995-06-21 2009-03-12 Oy Extracta Ltd. Verwendung von alpha-hydroxysäuren zur herstellung eines arzneimittels für die behandlung von entzündungen
US6071961A (en) * 1995-11-28 2000-06-06 Wider; Michael D. Antimicrobial composition and methods of use therefor
FI103704B (fi) * 1996-07-19 1999-08-31 Kemira Chemicals Oy Mikrobinvastainen koostumus, sen valmistusmenetelmä ja sen käyttö
US5965188A (en) * 1996-07-31 1999-10-12 Anitox Corporation Anti-bacterial amine derivatives
JPH11266796A (ja) * 1998-03-19 1999-10-05 Zenbi Shoji Kk 抗菌用飼料添加剤及び該抗菌用飼料添加剤を用いた抗菌方法
EP1294371B2 (fr) * 2000-06-20 2010-05-26 Nutrition Sciences Acides gras a chaines moyennes utilisables comme agents antimicrobiens

Also Published As

Publication number Publication date
EP1292291A2 (fr) 2003-03-19
WO2001097791A3 (fr) 2002-06-06
US20040116523A1 (en) 2004-06-17
WO2001097791A2 (fr) 2001-12-27
FR2810547A1 (fr) 2001-12-28
AU2001269239A1 (en) 2002-01-02
CA2413284A1 (fr) 2001-12-27

Similar Documents

Publication Publication Date Title
EP1346724A4 (fr) Remedes pour l'hepatite c
DZ1877A1 (fr) Forme posologiques d'azithromycine pour le traitement d'infection microbiennes.
EP1390029A4 (fr) Phenylindoles pour le traitement de l'infection par le vih
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
FR2810547B1 (fr) Utilisation d'acides en c2-c10 pour la prevention des infections a bacteries a gram negatif
FR2800614B1 (fr) Composition pour le traitement des infections des voies respiratoires
ITMI20001848A0 (it) Faramaci per l'incontinenza.
IT1289238B1 (it) Composizioni farmaceutiche per il trattamento di infezioni virali comprendenti una 4 arilcumarina
FR2818150B1 (fr) Composition pour le traitement d'objets destines a etre desinfectes
FR2797350B1 (fr) Plaque d'electrode pour accumulateur
FR2801508B1 (fr) Utilisation d'inhibiteurs d'hmg coa-reductase pour le traitement de la seborrhee
FR2810197B1 (fr) Melangeur-distributeur pour l'alimentation du betail
FR2804861B1 (fr) Dispositif d'assistance pour personnes agees ou handicapees
IT250463Y1 (it) Pallet ad elevata rigidita'
FR2833967B1 (fr) Utilisation de bacteries lactiques pour la production d'alpha-cetoglutarate
IT1320890B1 (it) Dispositivo per l'inserimento di articoli all'interno di relativicontenitori
FR2804331B1 (fr) Valve pour le traitement de l'hydrocephalie
FR2793786B1 (fr) Structures actives d'epuration pour le garnissage de reacteurs physiques et biologiques
IT250149Y1 (it) Dispositivo per l'applicazione di un prodotto
FR2795067B3 (fr) Structures actives d'epuration pour le dopage de reacteurs physico-biologiques
IT248622Y1 (it) Vassoio portavasetti ad impilabilita' facilitata
ITMI20001288A0 (it) Composti ad attivita' anti-hsv
EP1165598A4 (fr) Inhibiteur des plaquettes d'ankylostome
FR2826278B1 (fr) Utilisation d'agents antidiabetiques pour fabriquer un medicament ayant un effet cicatrisant
FR2791889B1 (fr) Suspension pharmaceutique buvable d'ibuprofene

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20060228